Picture of iRhythm Holdings logo

IRTC — iRhythm Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

iRhythm Technologies Inc reports results for the quarter ended in September - Earnings Summary

* iRhythm Technologies Inc  IRTC.OQ  reported a quarterly
adjusted
loss of 89 cents​​ per share for the quarter ended in September,
lower than the same quarter last year, when the company reported
EPS of -63 cents.  The mean expectation of twelve analysts for
the quarter was for a loss of 66 cents per share. Wall Street
expected results to range from -75 cents to -55 cents per share.
    * Revenue rose 20% to $124.60 million from a year ago;
analysts
expected $122.57 million. 
    * iRhythm Technologies Inc's reported EPS for the quarter
was a
loss of 89 cents​.
    * The company reported a quarterly loss of $27.12 million.
    * iRhythm Technologies Inc shares had fallen by 16.3% this
quarter and lost 15.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for iRhythm
Technologies Inc is $132.00 
This summary was machine generated from LSEG data November 2 at
09:59 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.66          -0.89          Missed
 Jun. 30 2023      -0.78          -0.61          Beat
 Mar. 31 2023      -0.90          -1.10          Missed
 Dec. 31 2022      -0.62          -0.67          Missed

Recent news on iRhythm Holdings

See all news